Belong.Life runs a large free social app where people with cancer share experiences and ask questions, plus Dave, an artificial intelligence mentor that answers cancer questions around the clock.
Belong.Life operates Belong Beating Cancer Together, which it describes as the world's largest social and professional network for cancer patients, alongside Dave, a conversational AI cancer mentor giving proactive guidance validated by physicians and informed by the peer community; the company says validation studies have been presented at ASCO and ESMO. It sells white label patient engagement and clinical trial recruitment solutions to pharmaceutical companies including Janssen, Bayer, AbbVie, AstraZeneca, Novartis, Roche, Sanofi, Takeda, Teva and MSD, reports millions of users worldwide, and holds HIPAA, GDPR and ISO 27001 certifications. The operating entity is Belong.Life Inc, a Delaware company, with parent Belongtail Ltd; the contact page lists an office at 276 5th Avenue, New York. No funding round, investor or founding year could be sourced from a primary document.
Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
A patient application with a navigation and question-answering layer, with trial matching and record collection inside the same app.